Disc Medicine ( NASDAQ: IRON ) on Friday priced a public offering of its common shares to raise $178 million. The company said it would offer 4,944,000 shares of its common stock at $36.00 per share.
All of the securities being sold in the offering are being offered by Disc. The net proceeds from the offering will be used to fund research and clinical development of its current or additional product candidates, as well as for working capital and other general corporate purposes. Leerink Partners is acting as sole bookrunning manager for the offering.
The offering is expected to close on June 17, 2024. Press Release . More on Disc Medicine Disc Medicine stock slides on failing to meet secondary goal for its EPP treatment Seeking Alpha’s Quant Rating on Disc Medicine Historical earnings data for Disc Medicine Financial information for Disc Medicine.
